Aviv Scientific Raises $40 Million In Series B Funding To Create The World’S First High Dimensional Omics Database Of The Aging Process
Aviv Scientific Raises $40 Million In Series B Funding To Create The World’S First High Dimensional Omics Database Of The Aging Process
09/22/21, 12:08 PM
Location
Money raised
$40 million
Round Type
series b
Today world leader in research and clinical treatment of age-related cognitive and functional decline to maximize human performance, Aviv Scientific, announces the closing of $40 million in a oversubscribed Series B funding round. Led by Israel’s largest public medical services conglomerate, Danel LTD; Jeff Horing’s Deep Insight Fund; the country’s most successful high-tech angels and entrepreneurs; international longevity and healthspan optimization focused investors; the Series B fundraise will accelerate the global rollout of its network of medical clinics and the development of the Aviv Aging Database. For the first time, in depth comprehensive OMICS data detailing the aging process in healthy adults will be captured, expediting the development of therapeutics and approaches to notably extend healthspan, and ultimately lifespan, in humans.
Company Info
Location
tel aviv, tel aviv district, israel
Additional Info
Aviv Scientific is a leader in age-related cognitive and functional decline and novel applications of hyperbaric oxygen therapy (HBOT) to maximize human performance. Based on an exclusive partnership with the world’s largest hyperbaric medicine research facility, the Sagol Center at Shamir Medical Center in Israel, Aviv Scientific is introducing a global network of clinics delivering a highly effective personalized treatment – The Aviv Medical Program. The three-month regimen designed to improve the aging process in healthy adults, was developed on over a decade of research and development under the scientific leadership of Shai Efrati, M.D., Chair of Aviv Scientific’s Medical Advisory Board and Director of the Sagol Center.